BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 20054770)

  • 1. Eisenmenger syndrome and juvenile rheumatoid arthritis--a case of double diagnosis.
    Ozdemir O; Agras PI; Hizli S; Guveloglu M; Kabakus N
    Kardiol Pol; 2009 Dec; 67(12):1377-80. PubMed ID: 20054770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Another patient with chromosome 18 deletion syndrome and juvenile rheumatoid arthritis.
    Rosen P; Hopkin RJ; Glass DN; Graham TB
    J Rheumatol; 2004 May; 31(5):998-1000. PubMed ID: 15124264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effect of bosentan therapy on cardiac function and symptomatic benefits in adult patients with Eisenmenger syndrome.
    Kaya MG; Lam YY; Erer B; Ayhan S; Vatankulu MA; Nurkalem Z; Meric M; Eren M; Eryol NK
    J Card Fail; 2012 May; 18(5):379-84. PubMed ID: 22555267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary hemosiderosis with juvenile rheumatoid arthritis: a case report.
    Topaloğlu R; Kiper N; Göçmen A; Varan B; Saatçi U
    Turk J Pediatr; 2000; 42(2):148-50. PubMed ID: 10936982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study.
    Galiè N; Beghetti M; Gatzoulis MA; Granton J; Berger RM; Lauer A; Chiossi E; Landzberg M;
    Circulation; 2006 Jul; 114(1):48-54. PubMed ID: 16801459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 4-1/2 year-old with a swollen knee.
    Reece G
    J Pediatr Health Care; 2004; 18(3):153, 161-2. PubMed ID: 15129217
    [No Abstract]   [Full Text] [Related]  

  • 7. Isolated tuberculous monoarthritis mimicking oligoarticular juvenile rheumatoid arthritis.
    Al-Matar MJ; Cabral DA; Petty RE
    J Rheumatol; 2001 Jan; 28(1):204-6. PubMed ID: 11196526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eisenmenger syndrome in the adult--experience with new drugs for the treatment of pulmonary hypertension.
    Agapito AF; Sousa L; Oliveira JA; Feliciano J; Cacela D; Quininha J
    Rev Port Cardiol; 2005 Mar; 24(3):421-31. PubMed ID: 15929625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial experience with bosentan therapy in patients with the Eisenmenger syndrome.
    Christensen DD; McConnell ME; Book WM; Mahle WT
    Am J Cardiol; 2004 Jul; 94(2):261-3. PubMed ID: 15246919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unfavorable prognosis in a patient with neglected juvenile idiopathic arthritis.
    Cen X; Yang M; Yin G; Xie Q
    J Clin Rheumatol; 2012 Oct; 18(7):370-1. PubMed ID: 23013847
    [No Abstract]   [Full Text] [Related]  

  • 11. [Bosenten and sildenafil in the treatment of Eisenmenger syndrome].
    Białkowski J
    Kardiol Pol; 2010 Feb; 68(2):248-9. PubMed ID: 20301040
    [No Abstract]   [Full Text] [Related]  

  • 12. Repair of ventricular septal defect with Eisenmenger syndrome after bosentan treatment.
    Hu L; Tan LH; Ye J
    J Card Surg; 2014 May; 29(3):401-2. PubMed ID: 24612361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bosentan for the treatment of pulmonary arterial hypertension associated with congenital cardiac disease.
    Kotlyar E; Sy R; Keogh AM; Kermeen F; Macdonald PS; Hayward CS; McNeil KD; Celermajer DS
    Cardiol Young; 2006 Jun; 16(3):268-74. PubMed ID: 16725066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bosentan-sildenafil association in patients with congenital heart disease-related pulmonary arterial hypertension and Eisenmenger physiology.
    D'Alto M; Romeo E; Argiento P; Sarubbi B; Santoro G; Grimaldi N; Correra A; Scognamiglio G; Russo MG; Calabrò R
    Int J Cardiol; 2012 Mar; 155(3):378-82. PubMed ID: 21081251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary vasoreactivity predicts long-term outcome in patients with Eisenmenger syndrome receiving bosentan therapy.
    D'Alto M; Romeo E; Argiento P; Santoro G; Sarubbi B; Gaio G; Mélot C; Russo MG; Naeije R; Calabrò R
    Heart; 2010 Sep; 96(18):1475-9. PubMed ID: 20668108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bosentan in Eisenmenger syndrome and chronic thromboembolic pulmonary hypertension.
    Kourouklis S; Christopoulos A; Liagkas K; Paradellis G; Kyriakides ZS
    Eur J Clin Invest; 2006 Sep; 36 Suppl 3():39-43. PubMed ID: 16919009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent gastrointestinal bleeding in a patient with Eisenmenger syndrome using bosentan.
    Sari I; Cam H; Dag MS; Durmus E; Kivrak T; Tigen K; Davutoglu V
    Curr Drug Saf; 2013 Sep; 8(4):282-3. PubMed ID: 24102362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effect of bosentan in adults versus children with pulmonary arterial hypertension associated with systemic-to-pulmonary shunt: does the beneficial effect persist?
    van Loon RL; Hoendermis ES; Duffels MG; Vonk-Noordegraaf A; Mulder BJ; Hillege HL; Berger RM
    Am Heart J; 2007 Oct; 154(4):776-82. PubMed ID: 17893008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic arthritis in a 3-year-old boy.
    Torrano RT; Church JA; Richards W; McCurdy D
    Ann Allergy; 1992 Mar; 68(3):215-8. PubMed ID: 1546815
    [No Abstract]   [Full Text] [Related]  

  • 20. Down patients with Eisenmenger syndrome: is bosentan treatment an option?
    Duffels MG; Vis JC; van Loon RL; Berger RM; Hoendermis ES; van Dijk AP; Bouma BJ; Mulder BJ
    Int J Cardiol; 2009 May; 134(3):378-83. PubMed ID: 18579234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.